Method to reduce insulin resistance and improve glucose tolerance using Parabacteroides goldsteinii
US10086019B1 · kind B1 · utility
1Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 23, 2017 |
| Grant date | Oct 2, 2018 |
| Priority date | — |
| Expiry date | Oct 23, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method to reduce insulin resistance and improve glucose tolerance by administering the probiotic bacterium Parabacteroides goldsteinii. This probiotic bacterium can therefore be used to treat insulin resistance, metabolic syndrome, and type 2 diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.